{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:41:01Z","timestamp":1790311261595,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001839","name":"University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001839","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.bioorg.2018.11.007","type":"journal-article","created":{"date-parts":[[2018,11,8]],"date-time":"2018-11-08T12:42:48Z","timestamp":1541680968000},"page":"569-579","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"special_numbering":"C","title":["Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus"],"prefix":"10.1016","volume":"83","author":[{"given":"Srikanth","family":"Gatadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitendra","family":"Gour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjulika","family":"Shukla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swetarka","family":"das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arunava","family":"Dasgupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.V.","family":"Madhavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidharth","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Nanduri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bioorg.2018.11.007_h0005","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1469-0691.2008.02074.x","volume":"14","author":"Marcel","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"10.1016\/j.bioorg.2018.11.007_h0010","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/hs.2014.0088","article-title":"Antimicrobial resistance is a global health emergency","volume":"13","author":"Toner","year":"2015","journal-title":"Health Secur."},{"key":"10.1016\/j.bioorg.2018.11.007_h0015","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus","volume":"340","author":"Smith","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bioorg.2018.11.007_h0020","doi-asserted-by":"crossref","first-page":"2836","DOI":"10.1172\/JCI68834","article-title":"Mechanisms of vancomycin resistance in Staphylococcus aureus","volume":"124","author":"Gardete","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.bioorg.2018.11.007_h0025","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1574-6968.1992.tb05089.x","article-title":"Co-transfer of vancomycin and other resistance genes from Enterococcus faecalis NCTC 12201 to Staphylococcus aureus","volume":"93","author":"Noble","year":"1992","journal-title":"FEMS Microbiol. Lett."},{"key":"10.1016\/j.bioorg.2018.11.007_h0030","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1473-3099(01)00091-3","article-title":"Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance","volume":"1","author":"Hiramatsu","year":"2001","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.bioorg.2018.11.007_h0035","first-page":"e02397","article-title":"Antimicrobial activity of dalbavancin against Staphylococcus aureus with decreased susceptibility to glycopeptides, daptomycin, and\/or linezolid from U.S. medical centers, Antimicrob. Agents","volume":"62","author":"Sader","year":"2018","journal-title":"Chemother."},{"key":"10.1016\/j.bioorg.2018.11.007_b0015","doi-asserted-by":"crossref","first-page":"e01784","DOI":"10.1128\/AAC.01784-17","article-title":"Limited effect of later-generation fluoroquinolones in the treatment of ofloxacin-resistant and moxifloxacin-susceptible multidrug-resistant tuberculosis","volume":"62","author":"Lee","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2018.11.007_b0020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S0140-6736(01)05410-1","article-title":"Linezolid resistance in a clinical isolate of Staphylococcus aureus","volume":"358","author":"Tsiodras","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.bioorg.2018.11.007_b0025","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","article-title":"Antibiotics for emerging pathogens","volume":"325","author":"Fischbach","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.bioorg.2018.11.007_b0030","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1136\/jcp.14.4.385","article-title":"Editorial","volume":"14","author":"Barber","year":"1961","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.bioorg.2018.11.007_b0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discovery."},{"key":"10.1016\/j.bioorg.2018.11.007_h0065","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1080\/13543776.2018.1432596","article-title":"Quinazoline and quinazolinone as important medicinal scaffolds: a comparative patent review (2011\u20132016)","volume":"28","author":"Hameed","year":"2018","journal-title":"Expert Opin. Ther. Pat."},{"key":"10.1016\/j.bioorg.2018.11.007_h0070","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.fitote.2017.05.001","article-title":"Pharmaceutical prospects of naturally occurring quinazolinone and its derivatives","volume":"119","author":"Hea","year":"2017","journal-title":"Fitoterapia."},{"key":"10.1016\/j.bioorg.2018.11.007_h0075","first-page":"083","article-title":"Design, synthesis and preliminary pharmacological screening (antimicrobial, analgesic and anti-inflammatory activity) of some novel quinazoline derivatives","volume":"7","author":"Dash","year":"2017","journal-title":"J. appl. pharm. sci."},{"key":"10.1016\/j.bioorg.2018.11.007_h0080","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.molstruc.2017.11.087","article-title":"Synthesis, spectroscopic characterization, antimicrobial evaluation and molecular docking study of novel triazine\u2013quinazolinone based hybrids","volume":"1156","author":"Dinari","year":"2018","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.bioorg.2018.11.007_h0085","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2174\/1871524917666170104142033","article-title":"Synthesis, molecular docking and evaluation of 3 -{4 - [2 - amino - 4 - (substituted phenyl) - 2H - [1, 3]oxazin \/ thiazin-6-yl}- 2 - phenyl - 3H -quinazolin-4-one derivatives for their anticonvulsant activity","volume":"18","author":"Jain","year":"2018","journal-title":"Cent. Nerv. Syst. Agents. Med Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0090","doi-asserted-by":"crossref","first-page":"4335","DOI":"10.1016\/j.ejmech.2009.05.008","article-title":"Synthesis, anticonvulsant and CNS depressant activity of some new bioactive 1-(4-substituted-phenyl)-3-(4-oxo-2-phenyl\/ethyl-4H-quinazolin-3-yl)-urea","volume":"44","author":"Kashawa","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_b0055","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.ejmech.2016.05.066","article-title":"Synthesis, anti-inflammatory, analgesic, COX-1\/2 inhibitory activities and molecular docking studies of substituted 2-mercapto-4 (3H)-quinazolinones","volume":"121","author":"Alaa","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0100","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11030-017-9792-1","article-title":"Synthesis of novel (E)-2-(4-(1H\u20131, 2, 4-triazol-1-yl) styryl)-4-(alkyl\/arylmethyleneoxy) quinazoline derivatives as antimicrobial agents","volume":"22","author":"Yang","year":"2018","journal-title":"Mol. Divers."},{"key":"10.1016\/j.bioorg.2018.11.007_h0105","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.micpath.2018.02.018","article-title":"In vitro evaluation of new 2-phenoxy-benzo [g][1,2,4] triazolo [1,5-a] quinazoline derivatives as antimicrobial agents","volume":"117","author":"Abuelizz","year":"2018","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2018.11.007_h0110","first-page":"134","article-title":"Synthesis and evaluation of antifungal activities of (3H)-quinazolin-4-one derivatives against tree plant fungi","volume":"8","author":"Ighachane","year":"2017","journal-title":"J. Mater. Environ. Sci."},{"key":"10.1016\/j.bioorg.2018.11.007_b0065","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1016\/j.bmcl.2017.05.064","article-title":"Synthesis and structure\u2013activity relationship study of novel quinazolinone based inhibitors of Mur A","volume":"27","author":"Hrast","year":"2017","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.11.007_h0120","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/s00044-017-2083-7","article-title":"New series of 4 (3H)-quinazolinone derivatives: syntheses and evaluation of antitumor and antiviral activities","volume":"27","author":"Abbas","year":"2018","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.11.007_h0125","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1021\/acs.jmedchem.7b01474","article-title":"Quinazolinone based anticancer agents: synthesis, antiproliferative SAR, antitubulin activity, and tubulin co-crystal structure","volume":"61","author":"Dohle","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0130","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1021\/jm400781h","article-title":"Discovery of selective small molecule type III Phosphatidylinositol 4-kinase alpha (PI4KIII\u03b1) inhibitors as anti hepatitis C (HCV) agents","volume":"57","author":"Leivers","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0135","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.ejmech.2012.04.010","article-title":"Design, synthesis and antiviral activity of novel quinazolinones","volume":"53","author":"Wang","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_b0080","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1021\/jm201507x","article-title":"Irreversible inhibition of epidermal growth factor receptor activity by 3-aminopropanamides","volume":"55","author":"Carmi","year":"2012","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.201700513","article-title":"Synthesis, cytotoxic, and antibacterial evaluation of quinazolinone derivatives with substituted amino moiety","volume":"15","author":"Zhan","year":"2018","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.bioorg.2018.11.007_h0150","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ejmech.2014.02.005","article-title":"Recent advances in the structural library of functionalized quinazoline and quinazolinone scaffolds: Synthetic approaches and multifarious applications","volume":"76","author":"Khan","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0155","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2014.10.084","article-title":"Synthetic approaches, functionalization and therapeutic potential of quinazoline and quinazolinone skeletons: The advances continue\u2026","volume":"90","author":"Khan","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0160","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/j.bmc.2016.03.031","article-title":"Quinazolines and quinazolinones as ubiquitous structural fragments in medicinal chemistry: an update on the development of synthetic methods and pharmacological diversification","volume":"24","author":"Khan","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_h0165","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1007\/s00044-012-0037-7","article-title":"Synthesis, analgesic, anti-inflammatory, and in vitro antimicrobial activities of some novel quinazolin-4 (3H)-one derivatives","volume":"22","author":"Saravanan","year":"2013","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.bioorg.2018.11.007_h0170","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1248\/bpb.26.1711","article-title":"Synthesis, Analgesic, Anti-inflammatory and Antibacterial Activities of Some Novel 2-Methyl-3-substituted Quinazolin-4-(3H)-ones","volume":"26","author":"Alagarsamy","year":"2003","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.bioorg.2018.11.007_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.jsps.2013.03.004","article-title":"Synthesis and biological evaluation studies of novel quinazolinone derivatives as antibacterial and anti-inflammatory agents","volume":"22","author":"Zayed","year":"2014","journal-title":"Saudi Pharm. J."},{"key":"10.1016\/j.bioorg.2018.11.007_b0105","first-page":"804","volume":"65","author":"Desai","year":"1988","journal-title":"J. Indian. Chem. Soc."},{"key":"10.1016\/j.bioorg.2018.11.007_b0110","doi-asserted-by":"crossref","first-page":"5011","DOI":"10.1021\/acs.jmedchem.6b00372","article-title":"Structure-Activity Relationship for the 4 (3 H)-Quinazolinone antibacterials","volume":"59","author":"Bouley","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bioorg.2018.11.007_b0115","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1016\/j.bmcl.2016.04.012","article-title":"Synthesis, biological evaluation and structure\u2013activity relationship of 2-styrylquinazolones as anti-tubercular agents","volume":"26","author":"Jadhavar","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.bioorg.2018.11.007_b0120","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1086\/510431","article-title":"New consensus guidelines from the clinical and laboratory standards institute for antimicrobial susceptibility testing of infrequently isolated or fastidious bacteria","volume":"44","author":"Jorgensen","year":"2007","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.bioorg.2018.11.007_h0200","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1128\/AAC.46.6.1914-1920.2002","article-title":"Mechanism of action of Melaleuca alternifolia (tea tree) oil on Staphylococcus aureus determined by time-kill, lysis, leakage, and salt tolerance assays and electron microscopy","volume":"46","author":"Carson","year":"2002","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.bioorg.2018.11.007_h0205","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0022-1759(83)90303-4","article-title":"Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays","volume":"65","author":"Mosmann","year":"1983","journal-title":"J. Immunol Methods"},{"key":"10.1016\/j.bioorg.2018.11.007_b0130","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1007\/BF01967378","article-title":"In vitro antimicrobial activity of 299 imipenem in combination with vancomycin or teicoplanin against Staphylococcus 300 aureus and Staphylococcus epidermidis","volume":"9","author":"Barr","year":"1990","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.bioorg.2018.11.007_h0215","doi-asserted-by":"crossref","first-page":"11521","DOI":"10.1038\/s41598-017-11575-5","article-title":"Diphenyleneiodonium chloride (DPIC) displays broad-spectrum bactericidal activity","volume":"7","author":"Pandey","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2018.11.007_h0220","doi-asserted-by":"crossref","first-page":"22571","DOI":"10.1038\/srep22571","article-title":"Antibacterial activity and mechanism of action of auranofin against multi-drug resistant bacterial pathogens","volume":"6","author":"Thangamani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bioorg.2018.11.007_b0140","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/nprot.2007.521","article-title":"Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substances","volume":"3","author":"Wiegand","year":"2008","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.bioorg.2018.11.007_b0145","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.ijantimicag.2012.09.015","article-title":"Activity of LL-37, CRAMP and antimicrobial peptide-derived compounds E2, E6 and CP26 against Mycobacterium tuberculosis","volume":"41","author":"Rivas-Santiago","year":"2013","journal-title":"Int. J. Antimicrob. Agents."},{"key":"10.1016\/j.bioorg.2018.11.007_b0150","first-page":"38","article-title":"In-vitro cytotoxicity activity of Solanum nigrum extract against Hela cell line and Vero cell line","volume":"1","author":"Patel","year":"2009","journal-title":"Int. J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.bioorg.2018.11.007_b0155","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.ijantimicag.2017.03.020","article-title":"Repurposing Ivacaftor for treatment of Staphylococcus aureus infections","volume":"50","author":"Thakare","year":"2017","journal-title":"Int. J. Antimicrob. Agents."}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206818309660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:46:51Z","timestamp":1758613611000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206818309660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":48,"alternative-id":["S0045206818309660"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.007","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Synthesis and evaluation of new 4-oxoquinazolin-3(4H)-yl)benzoic acid and benzamide derivatives as potent antibacterial agents effective against multidrug resistant Staphylococcus aureus","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2018.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}